|
|
|
| Setting the Standard in Cell and Gene Therapy, Together | Sartorius shares your mission to develop life-changing cell and gene therapies. Accelerate commercialization with end-to-end solutions that deliver reproducibility, scalability, and the quality needed to simplify regulatory approvals. From discovery, to process development, to clinical and commercial manufacturing, our portfolio of proven solutions helps you achieve faster time-to-market while saving costs. Together, we're setting the standard in cell and gene therapy. Learn more. |
|
|
|
|
On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Life Biosciences' CSO, Sharon Rosenzweig-Lipson, Ph.D., about the Boston-based biotech's cellular rejuvenation therapies for the treatment of age-related diseases. |
|
|
|
|
|
|
|
|
| Overcoming Challenges In AAV And LV Viral Vector Manufacturing | White Paper | By Mathias Kahl, Stephan Bauer, Dr. Daniel Kohler, Dr. Tobias Thom, Rico Hinrichs, Stefan Borutzki, Christina Pospisil, Dr. Rico Schmidt, Erik Arnold, and Dr. Thomas Kreisig, IDT Biologika | Manufacturing viral vectors leaves sponsors vulnerable to high costs, delays, and the possibility of failure. The right CDMO partner can help you reduce timelines and costs for viral vector production. |
|
|
|
|
|
| Stem cells are the backbone of many allogeneic therapies and where they come from affects development and supply chain logistics, particularly cryopreservation. What temperatures are ideal to maintain product potency? How do you build a reliable cold chain? How do you work with existing infrastructure to allow for an “off-the-shelf” therapy? Don’t miss the next Cell & Gene Live digital event! Registration is free thanks to the support of Charter Medical and Bio-Techne. |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
